Supplies of medicinal products
Dostawy produktów leczniczych
Poland · Nowy Sącz · how to bid here →
Your path to submission
- Deadline: 22 October at 00:00 — 34 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (400 awards, most recently August 2026) — the next award is due around September 2026 by that rhythm. The last award went to II.Shopcenter A. Kusina, P. Iwanek s.c..n = 400
- 54% of this buyer's awards went to companies that had already won here before (449 awards since 2015, spread over 196 companies). 46% went to new names.n = 449 awards since 2015
- The median procedure drew 3 bids (399 procedures with a bid count); 29% ended with a single bidder. Sector: median 3 bids.n = 399
- The award came in at a median 84% of the estimated value (34 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 81%.n = 34
- 6% of awards went to companies from abroad (449 awards with a known winner country). Sector average: 4%.n = 449
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 13/09/2026.
Foreign bidders
In Poland · Medical equipment & pharma, 5,178 contracts went to foreign companies over the last 3 years (of 274,171 recorded awards) — mostly from Germany, France, Czechia.
Typical field: median 3 (from 359 awards).
What the buyer is looking for
The summary in English is being prepared. The official description below is in the original language (DE).
Show original description (DE)
Przedmiot zamówienia obejmuje 18 części: Część nr 1: Doxorubicinum liposomanum nonpegylatum Część nr 2: Denosumabum Część nr 3: Octan abirateronu Część nr 4: Aprepitant Część nr 5: Kwas zoledronowy Część nr 6: Rytuksymab Część nr 7: Azacytydyna Część nr 8: Tretinoinum Część nr 9: Trabectedinum Część nr 10: Mesna Część nr 11: Peginterferon alfa-2a Część nr 12 : Vinorelbinum Część nr 13: Różne produkty lecznicze Część nr 14: Panitumumab Część nr 15 : Denosumab Część nr 16 : Aflibercept Część nr 17:Bosutynib Część nr 18: Paklitaksel w postaci nanocząsteczkowego kompleksu z albuminą
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL, POL.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Urtica Sp. z o.o. | 18 | 2024–2026 |
| SALUS INTERNATIONAL SP. Z O.O. | 17 | 2024–2026 |
| Fresenius Kabi Polska Sp. z o.o. | 14 | 2024–2026 |
| Baxter Polska Sp. z o.o. | 13 | 2015–2026 |
| Asclepios SA. | 12 | 2024–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on e-Zamówienia (Polen) → Registration, signature, fees — from the operator's bidder manual.